Melqart Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Melqart Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,700,000	Closed	-$3.24M	–	179
2020 Q4	$3.24M	Buy	4,700,000 +3,150,900	+203%	+$6.71M	0.24%	73
2020 Q3	$3.48M	Sell	1,549,100 -300,900	-16%	-$859K	0.39%	52
2020 Q2	$6.62M	Sell	1,850,000 -475,000	-20%	-$1.71M	0.82%	26
2020 Q1	$8.84M	Buy	2,325,000 +525,900	+29%	+$1.73M	0.87%	24
2019 Q4	$5.42M	Buy	+1,799,100	New	+$4.68M	0.45%	33

Other funds holding BMY.RT

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return